9EQ5 image
Deposition Date 2024-03-20
Release Date 2024-08-07
Last Version Date 2024-10-09
Entry Detail
PDB ID:
9EQ5
Keywords:
Title:
CryoEM Structure of Phenylalanine Ammonia Lyase from Planctomyces brasiliencis
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.17 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Histidine ammonia-lyase
Gene (Uniprot):Plabr_3153
Chain IDs:A, B, C, D
Chain Length:578
Number of Molecules:4
Biological Source:Rubinisphaera brasiliensis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MDO A ALA chromophore
Ligand Molecules
Primary Citation
Engineered Phenylalanine Ammonia-Lyases for the Enantioselective Synthesis of Aspartic Acid Derivatives.
Angew.Chem.Int.Ed.Engl. 63 e202406008 e202406008 (2024)
PMID: 38713131 DOI: 10.1002/anie.202406008

Abstact

Biocatalytic hydroamination of alkenes is an efficient and selective method to synthesize natural and unnatural amino acids. Phenylalanine ammonia-lyases (PALs) have been previously engineered to access a range of substituted phenylalanines and heteroarylalanines, but their substrate scope remains limited, typically including only arylacrylic acids. Moreover, the enantioselectivity in the hydroamination of electron-deficient substrates is often poor. Here, we report the structure-based engineering of PAL from Planctomyces brasiliensis (PbPAL), enabling preparative-scale enantioselective hydroaminations of previously inaccessible yet synthetically useful substrates, such as amide- and ester-containing fumaric acid derivatives. Through the elucidation of cryo-electron microscopy (cryo-EM) PbPAL structure and screening of the structure-based mutagenesis library, we identified the key active site residue L205 as pivotal for dramatically enhancing the enantioselectivity of hydroamination reactions involving electron-deficient substrates. Our engineered PALs demonstrated exclusive α-regioselectivity, high enantioselectivity, and broad substrate scope. The potential utility of the developed biocatalysts was further demonstrated by a preparative-scale hydroamination yielding tert-butyl protected l-aspartic acid, widely used as intermediate in peptide solid-phase synthesis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures